Condition: Irritable Bowel Syndrome With Constipation · Sponsor: Mayo Clinic
The purpose of this study is to determine if adult patients with IBS-C will report an overall greater improvement in IBS symptoms and quality of life when treated with a combination of linaclotide (standard of care medication) and immersive virtual reality (VR) therapy compared to those treated with linaclotide and sham (placebo) VR therapy.
This description comes directly from the study's public registry record.
Brian Lacy, MD, PhD · 904-953-6970 · lacy.brian@mayo.edu
Kristen Lozano · 904-953-4725 · Lozano.Kristen@mayo.edu
Always discuss trial participation with your own doctor first.
| Mayo Clinic Florida | Jacksonville, Florida, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05796388